Skip to main content
. 2016 May 18;104(1):205–214. doi: 10.3945/ajcn.115.129478

TABLE 2.

Vitamin D metabolites at baseline according to race1

Unadjusted median (IQR)
Adjusted median (95% CI)2
Overall (n = 208) Black (n = 57) White (n = 151) P3 Black (n = 57) White (n = 151) P4
Total 25(OH)D, ng/mL 26.0 (19.4–31.3) 22.0 (14.0–32.1) 26.8 (22.0–31.0) 0.011 20.3 (16.2, 24.5) 26.7 (25.2, 28.1) 0.026
Total 25(OH)D <20 ng/mL, % (n) 26.0 (54) 45.6 (26) 18.5 (28) <0.001
Directly measured free 25(OH)D, pg/mL 5.45 (4.17–6.76) 4.88 (3.40–6.26) 5.73 (4.54–6.84) 0.006 4.54 (3.72, 5.37) 5.66 (5.40, 5.92) 0.044
Measured free 25(OH)D as % total 25(OH)D 0.022 (0.019–0.026) 0.023 (0.02–0.026) 0.021 (0.019–0.025) NS 0.024 (0.021, 0.026) 0.022 (0.021, 0.023) NS
Calculated free 25(OH)D,5 pg/mL
 Monoclonal assay 9.17 (7.28–12.55) 11.89 (8.57–17.09) 8.84 (7.23–11.22) <0.001 11.83 (9.05, 14.61) 8.88 (8.36, 9.40) 0.080
 Polyclonal assay 9.14 (6.88–11.43) 7.75 (5.99–11.68) 9.52 (7.63–11.41) 0.008 8.32 (6.74, 9.90) 9.41 (8.85, 9.96) NS
Vitamin D–binding protein, mg/L
 Monoclonal assay 194 (133–247) 105 (82–154) 212 (172–254) <0.001 109 (90, 129) 220 (207, 232) <0.001
 Polyclonal assay 199 (174–235) 195 (176–234) 199 (173–235) NS 192 (173, 211) 201 (192, 209) NS
PTH, pg/mL 54.9 (43.6–69.5) 60.9 (46.3–85.1) 52.5 (42.8–65.3) 0.065 58.8 (47.5, 70.0) 51.2 (47.8, 54.6) NS
1

CaDDM, Calcium and Vitamin D for Diabetes Mellitus; DDM2, Vitamin D for Established Type 2 Diabetes; PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D.

2

Estimated from race-stratified quantile regression models adjusted for age, sex, BMI, season, vitamin D intake, and study (CaDDM or DDM2).

3

P values of group differences (black vs. white) for continuous variables were analyzed with the use of nonparametric Kruskal-Wallis tests for medians. Proportions were analyzed with the use of chi-square tests.

4

P values of group differences (black vs. white) for continuous variables are based on 2-sample z tests.

5

Based on the method described by Bikle et al. (7).